Welcome to our dedicated page for Cineverse news (Ticker: CNVS), a resource for investors and traders seeking the latest updates and insights on Cineverse stock.
Cineverse Corp. reports news on its entertainment technology and studio business, including streaming channel launches, content-distribution partnerships and updates to its Matchpoint® technology ecosystem. The company operates owned and operated digital properties, distributes films, series and podcasts across theatrical, home entertainment and streaming channels, and uses Matchpoint to prepare, deliver, monetize and analyze video assets across FAST, AVOD, SVOD and connected-TV platforms.
Recurring developments include new fandom-focused channels, platform distribution agreements, programmatic advertising and audience-network initiatives, social-video monetization, media supply-chain services through Giant Worldwide, and product announcements such as Matchpoint Hex™ for classification, discovery, programming and contextual advertising. Corporate updates also include leadership changes and capital-market activity tied to its public-company structure.
Cineverse (NASDAQ: CNVS) won the Emerging Technology award at DEG's 5th annual EnTech Awards on October 10, 2025 for cineSearch, powered by Matchpoint. cineSearch is an AI content search and discovery platform available to consumers and for commercial licensing to OEMs and streaming platforms.
Key product features include a customizable AI chat bot with launched persona Ava. The company reported cineSearch metrics of 90% lower average search time, 15.6% lower annual churn, and 24% average monthly savings. Cineverse also noted business licensing efforts and a Technology Leadership finalist recognition for Cineverse's CTO.
Cineverse (Nasdaq: CNVS) launched Matchpoint 3.0 on October 6, 2025, a major upgrade to its automated media supply‑chain platform with a refreshed brand identity at matchpoint.tv. Version 3.0 expands multi‑platform delivery (support for 4K and BXF), AI‑powered automation across Blueprint, Dispatch and Insights, conversational analytics, enhanced ad and privacy support (CCPA/GDPR), and new features for FAST, live and in‑car streaming. Management highlighted operational scale—ingesting and mastering 15,000 movies per month, delivering to 125+ platforms, and historically outsourcing ~$1.4M annually—positioning Matchpoint as an efficiency and cost‑savings tool for studios and streamers.
Cineverse (NASDAQ: CNVS) has announced its '31 Days of Halloween' programming event on its horror streaming service SCREAMBOX. The event features weekly channel takeovers by prominent horror content creators with significant social media followings, including Victoria Venin (751K followers) and Beckie-Ann Galentine (1.1M followers).
The highlight of the event is the exclusive premiere of 'Bloodsuckers and the Grimoire' on October 21, alongside popular titles like Terrifier 2 & 3, Hell House LLC trilogy, and other horror classics. SCREAMBOX is available across multiple platforms including iOS, Android, Prime Video, YouTube TV, Comcast, Cox, and screambox.com.
Cineverse (NASDAQ: CNVS) has announced the home release dates for The Toxic Avenger, a critically acclaimed action-comedy featuring Peter Dinklage. The film will be available on digital platforms starting September 30, 2025 at $24.99 (HD/SD EST) and $19.99 (HD/SD iVOD), followed by physical release on October 28, 2025.
The movie, which earned an 86% Rotten Tomatoes score, will be available in multiple formats including DVD, Blu-ray, and 4K Collector's Editions. Special features include behind-the-scenes content, director commentary, and a 40th Anniversary feature of the original 1984 film. The Amazon exclusive edition will include the original 1984 film in 4K UHD.
Cineverse (Nasdaq: CNVS) announced the integration of Fabric Data's Origin platform into its AI-powered cinematic search engine cineSearch. The enhancement expands cineSearch's capabilities to cover international territories and content from over 500 streaming services across English-speaking countries, up from its previous coverage of 63 U.S.-based services.
The integration adds global title availability, performance metrics, rich metadata, and multimedia assets to cineSearch, which launched in 2024 with its conversational virtual advisor Ava. The enhanced platform aims to deliver personalized content recommendations while providing strategic intelligence for platforms and studios globally.
Cineverse (Nasdaq: CNVS) has partnered with LG Channels to launch HISTORIAN, a new free ad-supported streaming television (FAST) channel from American Public Television. The channel features history-based programming including documentaries on war, art, politics, sports, and pop culture.
LG Channels will be the first platform to carry HISTORIAN, expanding on Cineverse's existing partnership which includes other channels like The Bob Ross Channel and Yu-Gi-Oh!. The channel's content includes notable programs such as the World War II Collection, Rick Steves' Special, and Curious Traveler.
HISTORIAN will offer regular programming stunts and special content aligned with historical dates like Patriots Day, Veterans Day, and Pearl Harbor Remembrance Day.
Cineverse (NASDAQ: CNVS) has strengthened its technology division with key executive appointments ahead of the IBC 2025 conference. John Smith joins as VP of Sales for Matchpoint™, the company's media supply chain platform, bringing extensive experience from Vubiquity and other major media companies.
The company is also expanding its cineSearch team, with Alison Maruca joining as VP of Product and Gabriel Berger as a contractor. CineSearch is an AI-powered content search and discovery platform now available for commercial licensing. Additionally, Andrew Goldstein and Craig Kierce have been appointed as directors of SaaS sales, focusing on independent studios and television networks respectively.
Cineverse (NASDAQ:CNVS) reports strong performance for its new release The Toxic Avenger Unrated, which has generated over $2 million in domestic box office revenue. The film, for which Cineverse acquired North American rights in perpetuity, has achieved the company's second-highest physical preorder numbers ever and is showing strong digital storefront engagement.
The horror/comedy remake, featuring Peter Dinklage and Kevin Bacon, was acquired, distributed, and marketed for less than $5 million. The film has received positive reception with 84% scores on Rotten Tomatoes from both critics and fans. Cineverse is partnering with Iconic Events Releasing and VVS for U.S. and Canadian distribution respectively.
Cineverse (Nasdaq: CNVS) has partnered with Xperi to launch four streaming apps in automobiles through DTS AutoStage Video Service Powered by TiVo™ and on TVs via TiVo OS. The company's streaming apps, including Verse Karaoke, Cineverse, RetroCrush, and Screambox, will be available in all new BMW models in the U.S., with Verse Karaoke already live.
Built using Cineverse's Matchpoint™ platform, this initiative targets the in-vehicle entertainment market, projected to reach $35.4 billion with 11.6% CAGR between 2024-2030. The integration allows seamless content viewing across home TVs and automobiles, offering access to streaming services, linear TV channels, and sports content through a unified interface.
Cineverse (NASDAQ: CNVS) has announced a groundbreaking social impact initiative tied to the release of The Toxic Avenger movie on August 29, 2025. The company has partnered with Undue Medical Debt, pledging to erase a minimum of $5 million in medical debt for qualifying individuals, with an additional $1 million in debt relief for every million dollars earned at the domestic box office.
Through this partnership, Cineverse will help individuals who are either below four times the federal poverty level or have medical debt exceeding 5% of their annual income. The nonprofit's model allows each dollar donated to eliminate approximately $100 of medical debt. The company has redirected its remaining marketing budget from promotional stunts to this charitable initiative, aligning with the film's theme of medical debt's impact on its main character.